This inventor holds 1 USPTO granted patent. Top assignees: Ea Pharma Co., Ltd., Niigata University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2019
Title: The Innovations of Shoji Kuwahara
Introduction
Shoji Kuwahara is a notable inventor based in Niigata, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of renal impairment and inner ear disorders. His work has the potential to impact many lives through innovative medical solutions.
Latest Patents
Kuwahara holds a patent for a megalin antagonist. This invention includes cilastatin or a pharmaceutically acceptable salt as an active component. It serves as a suppressant for renal impairment or inner ear disorders induced via megalin by at least one megalin ligand. The ligands selected for this invention include polymyxins, aminoglycoside antibiotics, glycopeptide antibiotics, cisplatin, and their pharmaceutically acceptable salts. He has 1 patent to his name.
Career Highlights
Throughout his career, Kuwahara has worked with prominent organizations such as Ea Pharma Co., Ltd. and Niigata University. His experience in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.
Collaborations
Kuwahara has collaborated with esteemed colleagues, including Yoshihisa Hori and Hiroshi Iwata. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Shoji Kuwahara's contributions to the field of pharmaceuticals demonstrate his commitment to innovation and improving healthcare solutions. His work continues to inspire future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile